SUPERNUS PHARMACEUTICALS INC. (SUPN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-10
08:37 am
Purchase
2021-12-3113GSupernus Pharmaceuticals, Inc.
SUPN
The Vanguard Group5,513,149
10.370%
215,071increase
(+4.06%)
Filing
History
2022-01-27
5:14 pm
Unchanged
2021-12-3113GSupernus Pharmaceuticals, Inc.
SUPN
BlackRock Inc.
BLK
8,451,022
15.900%
0
(Unchanged)
Filing
History
2022-01-26
09:16 am
Sale
2021-12-3113GSupernus Pharmaceuticals, Inc.
SUPN
BlackRock Inc.
BLK
8,451,022
15.900%
-461,779decrease
(-5.18%)
Filing
History
Goto Prev, 0, 1